Naproxen sodium for OB/GYN use, with special reference to pain states: a review
- PMID: 2875035
Naproxen sodium for OB/GYN use, with special reference to pain states: a review
Abstract
The effectiveness of naproxen sodium and its parent compound, naproxen, has been assessed in the treatment of a variety of obstetric and gynecologic problems, particularly pain states. This article summarizes the literature on the efficacy of the naproxen compounds in treatment of the following conditions: primary and secondary dysmenorrhea, insertion of a contraceptive intrauterine device, suction curettage, postpartum pain, pelvic inflammatory disease, gynecologic surgery, menorrhagia, premature labor and menopause. The data from the studies compiled demonstrate the usefulness of naproxen sodium or naproxen as an effective analgesic in treating pain and inflammation associated with these conditions.
PIP: Naproxen sodium, a nonsteroidal anti-inflammatory drug that blocks prostaglandin synthesis, has been shown to be effective for relief of mild to moderate pain. This article summarizes the literature on the efficacy of the naproxen compounds in the treatment of the following conditions: primary and secondary dysmenorrhea, IUD insertion, suction curettage, postpartum pain, pelvic inflammatory disease, gynecologic surgery, menorrhagia, premature labor, and menopause. Since naproxen does not affect the reproductive cycle, it appears to be ideal for obstetrics-gynecology use. Pediatricians, family practitioners, internists, surgeons, and geriatric specialists will also encounter patients requiring relief from pain caused by gynecologic pathology. The combined therapeutic use of nonsteroidal anti-inflammatory drugs and antibiotics for infections of the female reproductive tract appears indicated. The literature has established therapeutic success with naproxen and naproxen sodium as compared to a placebo in the treatment of dysmenorrhea and pain associated with IUD insertion, suction curettage, and postpartum conditions; joint pain in menopausal women; pain and inflammation associated with pelvic infections; and gynecologic surgery.
Similar articles
-
Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.Clin Ther. 2009 Jun;31(6):1192-208. doi: 10.1016/j.clinthera.2009.06.003. Clin Ther. 2009. PMID: 19695387 Clinical Trial.
-
Nonsteroidal anti-inflammatory agents in the treatment of primary dysmenorrhea.Clin Pharm. 1982 Jul-Aug;1(4):327-33. Clin Pharm. 1982. PMID: 6764392 Review.
-
Intrauterine devices: an effective alternative to oral hormonal contraception.Prescrire Int. 2009 Jun;18(101):125-30. Prescrire Int. 2009. PMID: 19637436
-
Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.Obstet Gynecol. 1978 Nov;52(5):583-7. Obstet Gynecol. 1978. PMID: 364357 Clinical Trial.
-
A rationale for the treatment of dysmenorrhea.J Reprod Med. 1980 Oct;25(4 Suppl):213-21. J Reprod Med. 1980. PMID: 7001020 Review.
Cited by
-
Management of menopause when estrogen cannot be used.Drugs. 1990 Aug;40(2):220-30. doi: 10.2165/00003495-199040020-00004. Drugs. 1990. PMID: 2226213 Review.
-
National assessment on the frequency of pain medication prescribed for intrauterine device insertion procedures within the Veterans Affairs Health Care System.PLoS One. 2025 Jan 10;20(1):e0308427. doi: 10.1371/journal.pone.0308427. eCollection 2025. PLoS One. 2025. PMID: 39792867 Free PMC article.
-
Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.Drugs. 1990 Jul;40(1):91-137. doi: 10.2165/00003495-199040010-00006. Drugs. 1990. PMID: 2202585 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous